Plastic Surgery and Integumentary System Procedures Market, By Procedure (Prefilled Syringe Biopsy, Excisional Biopsy, Incisional Biopsy, Culture and Sensitivity (CandS), Skin Tests), Operating Areas (Eyelids, Breast), Application (Allografts, Autografts, Infections), End-Users (Hospital, Clinics) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
The global Plastic Surgery and Integumentary System Market size was estimated at USD 3.02 billion in 2023 and is projected to reach USD 4.3 billion in 2030 at a CAGR of 5.2% during the forecast period 2023-2030.
Plastic surgery, a surgical specialty that has been in existence for decades, is defined as a medical procedure that involves the reconstruction, restoration or alteration of skin on any part of the human body. It is a meticulously executed and intricate technique that has both aesthetic and reconstructive purposes. The skillful and experienced reconstructive surgeons, who are experts in the field, play a pivotal role in improving and restoring the functional impairment of the body parts that may have been caused by a range of factors such as congenital defects, injury, and cancers, among others.
The plastic surgery and integumentary system procedures market is experiencing a surge in growth due to a multitude of factors. One such factor is the increasing number of qualified service providers and self-monitoring apps available in the market. Additionally, the low cost of surgical procedures and the increasing safety of such procedures have contributed to market growth. Furthermore, the rising demand for minimal invasive surgeries and the desire of customers to boost their self-esteem have also played a part in driving market growth. The rapidly growing geriatric population base and the increasing advancement in graft procedures and surgical techniques leading to a reduction in surgery costs are also major factors contributing to market growth. Moreover, there are other factors driving market growth, such as the rising technological advancements and modernization in the system used for the procedure, the increasing research and development activities in the healthcare sector, and the emergence of new markets. These factors will further create new opportunities for the plastic surgery and integumentary system procedures market.
The COVID-19 pandemic, a global health crisis of unprecedented proportions, has had a profound and far-reaching impact on a wide range of sectors, including the critical and indispensable medical and healthcare industry that serves as the backbone of our society. Among the many areas of medical practice that have been affected by this pandemic are the highly specialized and intricately nuanced fields of plastic surgery and procedures related to the integumentary system, which encompasses the complex and multifaceted domains of skin, hair, and nails. These fields, which have long been at the forefront of cutting-edge medical technology and innovation, have not been immune to the pervasive and wide-ranging impacts of COVID-19, which have had significant and potentially long-lasting consequences for both providers and patients alike.
One of the contributing factors to the exponential growth of the market for plastic surgery is the surging popularity of digital photography. The increase in demand for cosmetic procedures that enhance one's appearance in photos has been a direct result of this trend. Furthermore, the market has been bolstered by the growing number of qualified service providers, which has rendered plastic surgery more accessible to the general public. In addition, self-monitoring apps have played a significant role in the market's expansion by enabling individuals to monitor their progress and results following plastic surgery.
The market has also benefited from the low cost of surgical procedures and the increased safety of these procedures. Customers are increasingly drawn to plastic surgery as a means of boosting their self-esteem, and the growth of medical tourism has further contributed to the market's progression. Nevertheless, there are also associated risks with plastic surgery, such as competition from medical clinics that offer facial rejuvenation procedures and a lack of awareness among potential customers.
North America to Dominate the Market
Report Feature |
Descriptions |
---|---|
Growth Rate |
CAGR of 5.2% during the forecasting period, 2023-2030 |
Historical Data |
2019-2021 |
Forecast Years |
2023-2030 |
Base Year |
2022 |
Units Considered |
Revenue in USD billion and CAGR from 2023 to 2030 |
Report Segmentation |
By Procedure, Operating Areas, End-Users, Region. |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East, and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, and South Africa (50+ Countries Across the Globe) |
Companies Profiled |
Allergan; Johnson & Johnson; Merz Pharma; Galderma; Sientra; Cutera; Cynosure (Hologic); Syneron Candela; Valeant Pharmaceuticals; Alma Lasers; Sinclair Pharma; Anika Therapeutics; GC Aesthetics; Polytech Health & Aesthetics GmbH; BioHorizons; Stryker Corporation; Sinclair Pharma PLC |
Available Customization |
In addition to the market data for the Plastic Surgery and Integumentary System Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements. |
The Plastic Surgery and Integumentary System Market is segmented into various segments such as By Procedure, Operating Areas, End-Users, Region:
Based on Procedure
Based on the Operating Area
Based on the Application
Based on End-User
Based on region
The prominent players in the Plastic Surgery and Integumentary System market are